» Authors » Yong-Liang Chu

Yong-Liang Chu

Explore the profile of Yong-Liang Chu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 139
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jie L, Huang R, Sun W, Wei S, Chu Y, Huang Q, et al.
Mol Med Rep . 2022 Dec; 27(1). PMID: 36453210
Following the publication of the above article, an interested reader drew to the authors' attention that Fig. 4A on p. 921, showing the results from cell migration assay experiments, featured...
2.
Chen X, Wu J, Huang Q, Zhang J, Pen J, Huang Z, et al.
Exp Ther Med . 2018 Jun; 15(6):5221-5230. PMID: 29904406
Biqi capsule is a Traditional Chinese Medicine preparation for treating rheumatoid arthritis (RA), and clinical studies have indicatedthat its effect may be more beneficial than that of Western medicine. The...
3.
Chu Y, Jiang Y, Sun S, Zheng B, Xiong W, Li W, et al.
Discov Med . 2017 Dec; 24(132):133-146. PMID: 29272690
Objective: This study was designed to determine the differential profiles of long non-coding RNAs (lncRNAs) between rheumatoid arthritis (RA) and gouty arthritis (GA), which may lead to the discovery of...
4.
Chen X, Huang R, Yan J, Liu Z, Chu Y, Huang Q
Zhongguo Zhong Xi Yi Jie He Za Zhi . 2016 Jan; 35(11):1326-30. PMID: 26775479
Objective: To evaluate the clinical efficacy and safety of Huayu Tongbi Recipe (HTR) combined methotrexate (MTX) in treating refractory rheumatoid arthritis (RRA). Methods: Totally 167 RRA patients were assigned to...
5.
Huang Q, Wang M, Chen X, Yu W, Chu Y, He X, et al.
Oncotarget . 2015 Oct; 7(2):1193-202. PMID: 26498361
Objectives: This review stated the possible application of the active components of licorice, glycyrrhizin (GL) and glycyrrhetinic acid (GA), in rheumatoid arthritis (RA) treatment based on the cyclooxygenase (COX)-2/thromboxane A2...
6.
Chen X, Huang R, Huang Q, Chu Y, Yan J
Evid Based Complement Alternat Med . 2015 Sep; 2015:910376. PMID: 26379753
Chinese medicines are gaining wider acceptance. They have been used for treating rheumatoid arthritis (RA) for thousands of years, and the need to investigate the interaction between Chinese medicines and...
7.
Chen X, Huang Q, Yang S, Chu Y, Yan Y, Han L, et al.
Medicine (Baltimore) . 2015 Aug; 94(31):e1326. PMID: 26252320
The contributions of micro RNAs (miRNAs) to rheumatoid arthritis (RA) are beginning to be uncovered during the last decade. Many studies in efforts to use miRNAs as biomarkers in disease...
8.
Wang M, Huang Y, Huang R, Chen X, Zhou Y, Yu W, et al.
Discov Med . 2015 Feb; 19(102):23-32. PMID: 25636958
Introduction: To date, the etiology of rheumatoid arthritis (RA) remains largely unknown, and the therapies are still unsatisfactory. The biosynthesis of thromboxane A2 (TxA2) is increased in RA patients, suggesting...
9.
Jie L, Huang R, Sun W, Wei S, Chu Y, Huang Q, et al.
Mol Med Rep . 2014 Oct; 11(2):917-23. PMID: 25351421
Cysteine‑rich angiogenic inducer 61 (Cyr61) is a novel molecule that has been shown to be increased in the synovial tissues of patients with rheumatoid arthritis (RA). The present study was...
10.
Huang R, Chu Y, Huang Q, Chen X, Jiang Z, Zhang X, et al.
PLoS One . 2014 Apr; 9(4):e93690. PMID: 24695790
18β-Glycyrrhetinic acid (18β-GA) is a bioactive component of licorice. The anti-cancer activity of 18β-GA has been studied in many cancer types, whereas its effects in lung cancer remain largely unknown....